Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022

SELL
$225.82 - $368.51 $4,516 - $7,370
-20 Closed
0 $0
Q2 2021

Aug 03, 2021

SELL
$129.91 - $234.98 $3,247 - $5,874
-25 Reduced 55.56%
20 $5,000
Q2 2020

Aug 04, 2020

BUY
$29.67 - $80.0 $1,335 - $3,600
45 New
45 $3,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Rpg Investment Advisory, LLC Portfolio

Follow Rpg Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rpg Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rpg Investment Advisory, LLC with notifications on news.